• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回顾性研究 BRAF 突变与甲状腺乳头状癌的 CT 特征。

Retrospective study of BRAF mutation and CT features of papillary thyroid carcinoma.

机构信息

Department of General Surgery, Zhongshan Hospital of Xiamen University, Xiamen, Fujian, China.

Department of Medical Imaging, Zhongshan Hospital of Xiamen University, Xiamen, Fujian, China.

出版信息

PeerJ. 2024 Jan 24;12:e16810. doi: 10.7717/peerj.16810. eCollection 2024.

DOI:10.7717/peerj.16810
PMID:38282867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10821721/
Abstract

OBJECTIVE

This study aimed to examine the correlation between BRAF status and computed tomography (CT) imaging characteristics in papillary thyroid carcinoma (PTC) and determine if suspicious CT imaging features could predict BRAF status.

METHODS

This retrospective study included patients with pathologically confirmed PTC at the Department of Thyroid Surgery of Zhongshan Hospital, Xiamen University, between July 2020 and June 2022. We compared the clinicopathologic factors and CT findings of nodules with and without the mutation, and the multiple logistical regression test was used to determine independent parameters of the BRAF mutation.

RESULTS

This study included 381 patients with PTC, among them, BRAF mutation was detected in 314 patients (82.4%). Multivariate logistic regression analysis showed that gender (OR = 0.542, 95% CI [0.296-0.993], = 0.047) and shape (OR = 0.510, 95% CI [0.275-0.944], = 0.032) were associated with BRAF mutation.

CONCLUSIONS

Compared to BRAF mutation-negative, BRAF-positive PTC lesions were more likely to be found in female patients and were characterized by irregular shape. However, the CT imaging finding is not enough to predict BRAF status, but an indication.

摘要

目的

本研究旨在探讨甲状腺乳头状癌(PTC)中 BRAF 状态与计算机断层扫描(CT)成像特征的相关性,并确定可疑 CT 成像特征是否可预测 BRAF 状态。

方法

本回顾性研究纳入了 2020 年 7 月至 2022 年 6 月在厦门大学附属中山医院甲状腺外科经病理证实为 PTC 的患者。我们比较了有突变和无突变结节的临床病理因素和 CT 发现,并使用多因素逻辑回归检验确定 BRAF 突变的独立参数。

结果

本研究共纳入 381 例 PTC 患者,其中 314 例(82.4%)检测到 BRAF 突变。多因素逻辑回归分析显示,性别(OR=0.542,95%CI[0.296-0.993], =0.047)和形状(OR=0.510,95%CI[0.275-0.944], =0.032)与 BRAF 突变相关。

结论

与 BRAF 突变阴性相比,BRAF 阳性 PTC 病变更可能发生在女性患者中,且形状不规则。然而,CT 成像发现不足以预测 BRAF 状态,仅为提示。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/10821721/0188ef38b189/peerj-12-16810-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/10821721/078f05272504/peerj-12-16810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/10821721/0188ef38b189/peerj-12-16810-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/10821721/078f05272504/peerj-12-16810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/10821721/0188ef38b189/peerj-12-16810-g002.jpg

相似文献

1
Retrospective study of BRAF mutation and CT features of papillary thyroid carcinoma.回顾性研究 BRAF 突变与甲状腺乳头状癌的 CT 特征。
PeerJ. 2024 Jan 24;12:e16810. doi: 10.7717/peerj.16810. eCollection 2024.
2
Clinical Analysis of BRAF Mutation and Its Correlation With Sonographic Image Characteristics in Papillary Thyroid Carcinoma in Chinese Coastal Areas.中国沿海地区甲状腺乳头状癌中BRAF突变的临床分析及其与超声图像特征的相关性
Am Surg. 2020 May;86(5):450-457. doi: 10.1177/0003134820919734.
3
Integrating BRAF mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.整合 BRAF 突变、超声及临床病理特征预测甲状腺乳头状癌中央区淋巴结转移风险
BMC Cancer. 2022 Apr 27;22(1):461. doi: 10.1186/s12885-022-09550-z.
4
Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.甲状腺乳头状癌的临床病理特征,包括BRAF V600E突变状态及PET/CT检查结果
Clin Endocrinol (Oxf). 2017 Jul;87(1):73-79. doi: 10.1111/cen.13335. Epub 2017 Apr 18.
5
Association Between BRAF Mutation and the American College of Radiology Thyroid Imaging, Reporting and Data System in Solitary Papillary Thyroid Carcinoma.BRAF 突变与孤立性甲状腺乳头状癌的美国放射学会甲状腺影像报告和数据系统之间的关系。
Acad Radiol. 2019 Feb;26(2):154-160. doi: 10.1016/j.acra.2018.05.010. Epub 2018 Jun 23.
6
Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAF , and ultrasound elastography.应用细针穿刺细胞学、BRAF 及超声弹性成像对弥漫硬化型甲状腺乳头状癌与桥本甲状腺炎的鉴别诊断。
J Clin Ultrasound. 2022 Sep;50(7):942-950. doi: 10.1002/jcu.23260. Epub 2022 Jul 2.
7
Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.BRAF(V600E)突变与大量传统型乳头状甲状腺癌患者超声特征及临床病理特征的相关性
PLoS One. 2014 Oct 22;9(10):e110868. doi: 10.1371/journal.pone.0110868. eCollection 2014.
8
Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF mutation.根据甲状腺过氧化物酶抗体和 BRAF 突变的存在,弥漫性淋巴细胞浸润与甲状腺乳头状癌侵袭性的关系。
Head Neck. 2018 Oct;40(10):2271-2279. doi: 10.1002/hed.25327. Epub 2018 Jun 22.
9
Predicting BRAFV600E mutations in papillary thyroid carcinoma using six machine learning algorithms based on ultrasound elastography.基于超声弹性成像的 6 种机器学习算法预测甲状腺乳头状癌 BRAFV600E 突变。
Sci Rep. 2023 Aug 3;13(1):12604. doi: 10.1038/s41598-023-39747-6.
10
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.细针抽吸细胞学检查甲状腺乳头状癌时 BRAF V600E 基因突变呈假阴性。
World J Surg Oncol. 2017 Nov 13;15(1):202. doi: 10.1186/s12957-017-1266-5.

本文引用的文献

1
BRAF V600E mutation in papillary thyroid carcinoma: it's relation to clinical features and oncologic outcomes in a single cancer centre experience.甲状腺乳头状癌中的BRAF V600E突变:单癌症中心经验中其与临床特征及肿瘤学结局的关系
Endocr Connect. 2021 Nov 25;10(12):1531-1537. doi: 10.1530/EC-21-0410.
2
Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification.甲状腺肿瘤病理学分类的更新:对世界卫生组织分类的综述。
Endocrinol Metab (Seoul). 2020 Dec;35(4):696-715. doi: 10.3803/EnM.2020.807. Epub 2020 Dec 2.
3
Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.
低危型甲状腺乳头状癌的早期诊断结果往往是过度治疗而非更好的生存。
Front Endocrinol (Lausanne). 2020 Oct 6;11:571421. doi: 10.3389/fendo.2020.571421. eCollection 2020.
4
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.甲状腺乳头状癌-侵袭性变异体及其对管理的影响:叙事性综述。
Adv Ther. 2020 Jul;37(7):3112-3128. doi: 10.1007/s12325-020-01391-1. Epub 2020 Jun 1.
5
Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations.甲状腺乳头状癌:遗传改变与分子生物标志物研究。
Int J Med Sci. 2019 Feb 28;16(3):450-460. doi: 10.7150/ijms.29935. eCollection 2019.
6
miRNA-299-5p regulates estrogen receptor alpha and inhibits migration and invasion of papillary thyroid cancer cell.微小RNA-299-5p调节雌激素受体α并抑制甲状腺乳头状癌细胞的迁移和侵袭。
Cancer Manag Res. 2018 Nov 22;10:6181-6193. doi: 10.2147/CMAR.S182625. eCollection 2018.
7
Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned.前列腺癌和甲状腺癌的主动监测:临床范例的演变和经验教训。
Nat Rev Clin Oncol. 2019 Mar;16(3):168-184. doi: 10.1038/s41571-018-0116-x.
8
Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the "Right" TIRADS.在提高诊断准确性的同时减少不必要的甲状腺活检:走向“正确”的 TIRADS。
J Clin Endocrinol Metab. 2019 Jan 1;104(1):95-102. doi: 10.1210/jc.2018-01674.
9
Can Suspicious Ultrasound Features Predict BRAFV600E Status in Papillary Thyroid Cancer?可疑超声特征能否预测甲状腺乳头状癌中的BRAFV600E状态?
Eur Thyroid J. 2018 Aug;7(4):205-210. doi: 10.1159/000489851. Epub 2018 Jul 5.
10
Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto's Thyroiditis.BRAF V600E 突变与桥本甲状腺炎合并与不合并的甲状腺乳头状癌患者的超声特征之间的关联。
Sci Rep. 2017 Jul 7;7(1):4899. doi: 10.1038/s41598-017-05153-y.